Drug Safety News
-
The number of dead pigs found in Shanghai’s Huangpu river climbed to at least 6,600 as the official Xinhua News Agency reported a farm in neighboring Zhejiang province confessed to dumping carcasses in the water.
-
Shanghai stepped up inspections and retrieval of dead pigs from its main river after the number of carcasses found in China’s largest commercial city climbed to at least 6,600 today.
-
Shanghai said it’s increasing the frequency of water quality checks after the number of dead pigs found upriver from China’s largest commercial city more than doubled from the previous tally to almost 6,000.
-
AbbVie Inc., the drugmaker that was split off from Abbott Laboratories at the start of this year, and biotechnology company InterMune Inc. sued the European Union’s pharmaceuticals regulator in a bid to block publication of clinical-trial data.
-
Shanghai said it detected traces of a virus that may have killed pigs found in a river that runs through the city as the government reported the number of dead animals retrieved from the water more than doubled.
-
China unveiled a plan to elevate the food and drug regulator to a ministry-level body with broader powers, underpinning the government’s pledge to crack down on safety violations and better protect consumers.
-
Without a growing economy that creates more high-paying jobs, both President Barack Obama and congressional Republicans face the unpalatable prospect of much higher taxes or reductions to popular programs (or both). Growth is the best way to cut this Gordian knot.
-
The U.S. Supreme Court made it easier for shareholders to press class action securities-fraud suits, ruling that Amgen Inc. must defend against claims that it misled investors about the safety of two drugs for anemia.
-
Hemofarm AD, a Serbian drugmaker owned by Stada Arzneimittel AG, said it fixed contamination threats in its aseptic production line found by the U.S. Food and Drug Administration, which halted its exports to the U.S.
-
Half of the 21 drugs pulled from the market in the U.S. for safety reasons since 1995 involved heart complications, a finding that is spurring Congress and doctors to call for closer government review of side effects.
|
|
Most Popular on Bloomberg
|
| |